Developing new models for drug testing to understand the biology and mechanisms of drug resistance in AML
Dr Laura Bray, Queensland University of Technology, Institute of Health and Biomedical Innovation (Brisbane)
Funding period: 2019-2021.
This research project is kindly supported through The Bourne Foundation.
Studies have shown that the standard culture of leukaemia cells for research purposes, does not accurately mimic the natural environment of the bone marrow in the human body, hindering the translation of lab results to the clinic.
This study aims to develop new models for drug testing that give us information about the biology of acute myeloid leukaemia development and mechanisms of drug resistance
Last updated on January 29th, 2021
Developed by the Leukaemia Foundation in consultation with people living with a blood cancer, Leukaemia Foundation support staff, haematology nursing staff and/or Australian clinical haematologists. This content is provided for information purposes only and we urge you to always seek advice from a registered health care professional for diagnosis, treatment and answers to your medical questions, including the suitability of a particular therapy, service, product or treatment in your circumstances. The Leukaemia Foundation shall not bear any liability for any person relying on the materials contained on this website.